Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Luminex Corporation    LMNX

LUMINEX CORPORATION (LMNX)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/11/2017 12/12/2017 12/13/2017 12/14/2017 12/15/2017 Date
20.27(c) 20.39(c) 20.52(c) 20.37(c) 20.55(c) Last
111 324 191 787 552 465 134 019 488 035 Volume
-1.31% +0.59% +0.64% -0.73% +0.88% Change
More quotes
Financials ($)
Sales 2017 305 M
EBIT 2017 41,4 M
Net income 2017 36,2 M
Finance 2017 124 M
Yield 2017 1,17%
Sales 2018 311 M
EBIT 2018 48,1 M
Net income 2018 22,4 M
Finance 2018 150 M
Yield 2018 1,27%
P/E ratio 2017 24,46
P/E ratio 2018 36,05
EV / Sales2017 2,56x
EV / Sales2018 2,42x
Capitalization 905 M
More Financials
Company
Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries.The company was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX. 
More about the company
Surperformance© ratings of Luminex Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on LUMINEX CORPORATION
12/13 LUMINEX CORPORATION : Declares Fourth Quarter Cash Dividend
12/13 LUMINEX : Maintenance for flow cytometry based analyzers for transfusion medicin..
11/24 CHROMEDX : Accepts Proposal; Signs LOI with Diagnostic Marketing Experts to Cond..
11/21 LUMINEX : Researchers Submit Patent Application, "Instrument for Cassette for Sa..
11/14 LUMINEX CORPORATION : To Present At The 29th Annual Piper Jaffray Healthcare Con..
11/14 LUMINEX : Discover The Versatile Luminex GigaCore 10 At LDI
11/09 LUMINEX CORPORATION : Receives FDA Clearance for ARIES Group A Strep Assay
11/06 THERMO FISHER SCIENTIFIC : Webinar Sponsored by Thermo Fisher Scientific Address..
10/31 LUMINEX : Receives FDA Clearance for ARIES Group A Strep Assay
10/31 LUMINEX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
12/08DJROYAL PHILIPS : Philips Buys VitalHealth for Undisclosed Sum
12/08 SAFRA CATZ : Oracle's Safra Catz among two new members named to Disney board
12/05DJROYAL PHILIPS : Philips Buys Interoperability Provider Forcare for Undisclosed S..
11/29DJROYAL PHILIPS : Cuts Stake in Philips Lighting With EUR547 Million Share Sale
11/28 PHILIPS LIGHTING : cuts holding in Lighting with $600 mln share sale
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
12/13 Luminex declares $0.06 dividend
12/05 GenMark's Credibility Is Dented, But The Sell-Off Is Excessive
11/14 Can Luminex Light The Way?
10/31 FDA clears Luminex's ARIES Strep test
10/30 Luminex's (LMNX) CEO Homi Shamir on Q3 2017 Results - Earnings Call Transcrip..
Chart LUMINEX CORPORATION
Duration : Period :
Luminex Corporation Technical Analysis Chart | LMNX | US55027E1029 | 4-Traders
Technical analysis trends LUMINEX CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 6
Average target price 20,6 $
Spread / Average Target 0,24%
EPS Revisions
Managers
NameTitle
Nachum Shamir President, Chief Executive Officer & Director
G. Walter Loewenbaum Chairman
Harriss T. Currie Chief Financial Officer, Treasurer & SVP-Finance
Tadd S. Lazarus Chief Medical Officer & Senior Vice President
Thomas W. Erickson Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
LUMINEX CORPORATION1.43%905
THERMO FISHER SCIENTIFIC INC.35.70%76 695
DANAHER20.95%65 387
INTUITIVE SURGICAL75.54%41 443
ROYAL PHILIPS12.16%36 149
BOSTON SCIENTIFIC CORPORATION18.86%35 401